Preventing Fetal Body and Brain Size Reduction in Low-income Smoking Mothers: A Randomized Clinical Trial
Completed · Not applicable
Conditions studied: Fetal Body Size, Fetal Brain Size
In brief
The purpose of this study is to find out if folic acid prevents of the reduction of fetal body and brain size in infants whose mothers smoke.
Key facts
- Study ID
- NCT01248260
- Run by
- Hamisu Salihu
- People needed
- 495
- Starts
- 2011-02-01
- Expected to finish
- 2016-08-01
- Last updated by the study team
- 2019-02-15
Who can join
Age: 18 and older, up to 44. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- ((1) Smoker, based on presence of detectable cotinine in saliva (biomarker).; (2) Ages 18-44 years; (3) Singleton gestation (< 20 weeks), confirmed by sonogram; (4) Residents of Tampa, Florida or surrounding area in order to facilitate follow-up and reduce attrition rate.
You may not qualify if…
- (a) an indication for chronic blood transfusion. Women receiving chronic blood transfusions will not be enrolled, as transfused red blood cells (RBC) can result in inaccurate analysis of folate RBC levels88; (b) generalized seizure disorder treated with anti-convulsant medication: Patients with generalized seizure disorder treated with anticonvulsant medication will be excluded because of the potential association with folic acid deficiency88.
Where it is running
- University of South Florida, College of Public Health, Department of Epidemiology and Biostatistics — Tampa, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.